Utility of ICD Electrograms During Ventricular Tachycardia Ablation

December 9, 2022 updated by: Fundación Hospital de Madrid

Aid of Recording ICD Electrograms During Monomorphic Ventricular Tachycardia Ablation Procedures

With the increasing use of implantable cardioverter defibrillators (ICD) for primary prevention in patients with structural heart disease, an increasing number of patients are expected to develop their first episode of monomorphic ventricular tachycardia (VT) after an ICD is in place and the only documentation of the clinical arrhythmia will be the ICD electrogram (EG). The absence of a 12-lead ECG in patients with an ICD and sustained monomorphic VT represents a limitation when performing treatment with radiofrequency (RF) ablation. The analysis of ICD-EG during a RF ablation procedure is expected to provide a reference "model" of VT with clinical expression consisting of the electrical signal of the ICD during VT (which otherwise is not generally possible to obtain in ICD patients). This will allow for a more targeted approach to the substrate of the VT with clinical expression because: 1) if VT is induced by programmed stimulation, one can tell whether it is with clinical expression or not, and 2) if VT is not induced, ventricular pacing could be performed based on the comparative analysis of morphology and activation times of ICD-EG. These approaches will result in improved outcomes of the ablation procedure.

Study Overview

Study Type

Interventional

Enrollment (Actual)

260

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alicante, Spain
        • Hospital General Universitario
      • Barcelona, Spain
        • Hospital del Mar
      • Barcelona, Spain
        • Hospital de la Santa Creu i Sant Pau
      • Bilbao, Spain
        • Hospital Universitario de Basurto
      • Burgos, Spain
        • Hospital Universitario de Burgos
      • Granada, Spain
        • Hospital Universitario Virgen de las Nieves
      • Las Palmas, Spain
        • Hospital Universitario Insular de Gran Canaria
      • Madrid, Spain
        • Hospital Universitario La Paz
      • Madrid, Spain
        • Hospital Universitario Ramon Y Cajal
      • Madrid, Spain
        • HM hospitales
      • Murcia, Spain
        • Hospital Universitario Virgen de la Arrixaca
      • Sevilla, Spain
        • Hospital Universitario Nuestra Señora de Valme
      • Toledo, Spain
        • Hospital Virgen De La Salud
      • Valencia, Spain
        • Hospital Clinico Universitario

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 years or older
  • Clinical indication for RF catheter ablation
  • Presence of an implanted ICD
  • At least 1 episode of spontaneous sustained monomorphic VT documented with ICD electrogram
  • Presence of structural heart disease
  • Able to obtain signed informed consent and willing to comply with study activity requirements

Exclusion Criteria:

  • It is anticipated that data can not be obtained during follow-up
  • Unwilling or unable to provide informed consent
  • Women who are or may potentially be pregnant
  • Patients who are participating in another clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Conventional RF catheter ablation
Conventional RF ablation will be performed without using ICD-EG information
RF catheter ablation will be performed as usually done by each center. No ICD EGMs will be obtained and used during the ablation procedure (do not place the programming head over the ICD generator).
Other: Investigational RF Catheter Ablation using ICD-EG information
RF Catheter Ablation will be performed using ICD-EG information
RF ablation procedure will be performed with the programming head over the ICD generator. ICD EGMs will be registered every time VT is induced and during ventricular pacing. ICD EGMs obtained during ablation procedure will be compared with the EGMs of the registered spontaneus VT and used to locate appropriate ablation sites.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of patients free of VT recurrence
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction in number of VT recurrence
Time Frame: 6 months
6 months
Reduction in the proportion of patients free of VT recurrence
Time Frame: 6 months
6 months
Reduction in the proportion of patients free of recurrence in patients in whom 12-lead ECG of the spontaneous VT is not available and in those in whom hemodinamically tolerated VT is not induced
Time Frame: 6 months and total follow-up
6 months and total follow-up
Improvement of spatial resolution of the ICD-EG after information from local ventricular endocardial acceleration is added
Time Frame: 6 months
This outcome will be studied from the stored signal together with the ICD-EG on the device in the subgroup of patients with a device that allows to obtain this parameter. In the remaining patients, signals will be obtained noninvasively with a seismocardiogram using a highly sensitive accelerometer located in the sternal midline of the xiphoid process and simultaneously synchronized with the ECG.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jesus Almendral, MD, HM hospitales

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

March 1, 2022

Study Completion (Actual)

March 1, 2022

Study Registration Dates

First Submitted

September 14, 2014

First Submitted That Met QC Criteria

October 22, 2014

First Posted (Estimate)

October 24, 2014

Study Record Updates

Last Update Posted (Estimate)

December 13, 2022

Last Update Submitted That Met QC Criteria

December 9, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sustained Monomorphic Ventricular Tachycardia

Clinical Trials on Conventional RF catheter ablation

3
Subscribe